YIXINTANG PHARMACEUTICAL GROUP CO., LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 20.03 CNY | -0.84% |
|
-1.23% | -13.51% |
Chart calendar Yixintang Pharmaceutical Group Co., Ltd.
4.QNnDHIFUee_uYgu5uF6JRWR3GkXxXEEMXcDrmobMXtQ.Irr3Vu8VLoO2CEf162_LMQIbchWFHihLOZGpwL70J4RwjKsu7TVNoK8xfA~b3a7f2acc06e442bf97b62381ba66267
Upcoming events on Yixintang Pharmaceutical Group Co., Ltd.
Past events on Yixintang Pharmaceutical Group Co., Ltd.
| 2023-10-30 | Q3 2023 Earnings Release |
| 2023-08-29 | Q2 2023 Earnings Release |
| 2023-04-20 | Q1 2023 Earnings Release |
| 2022-10-27 | Q3 2022 Earnings Release |
| 2022-08-29 | Interim 2022 Earnings Release |
| 2022-04-29 | Q1 2022 Earnings Release |
| 2022-03-29 | FY 2021 Earnings Release |
| 2021-10-29 | Q3 2021 Earnings Release |
| 2021-08-18 | Interim 2021 Earnings Release |
| 2021-04-28 | Q1 2021 Earnings Release |
| 2021-03-15 | FY 2020 Earnings Release |
| 2020-10-28 | Q3 2020 Earnings Release |
| 2020-08-18 | Interim 2020 Earnings Release |
| 2020-05-29 02:00 am | Extraordinary Shareholders Meeting |
| 2020-04-28 | Q1 2020 Earnings Release |
| 2020-04-14 02:00 am | Annual General Meeting |
| 2020-03-19 | FY 2019 Earnings Release |
| 2020-01-03 01:00 am | Extraordinary Shareholders Meeting |
| 2019-11-06 01:00 am | Extraordinary Shareholders Meeting |
| 2019-10-24 | Q3 2019 Earnings Release |
Past dividends on Yixintang Pharmaceutical Group Co., Ltd.
| 2023-05-25 | Annual 0.4 CNY |
| 2022-04-28 | Annual 0.3 CNY |
| 2021-04-20 | Annual 0.3 CNY |
| 2020-04-29 | Annual 0.3 CNY |
| 2019-04-02 | Annual 0.3 CNY |
| 2018-06-13 | Annual 0.3 CNY |
| 2017-04-12 | Annual 0.2 CNY |
| 2016-04-12 | Annual 0.5 CNY |
| 2015-04-08 | 0.6 CNY |
Annual results
| Fiscal Period | December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|
|
Net sales Million CNY | Released Forecast Spread | 9 176 9 411 -2.49% | 10 479 10 595 -1.09% | 12 656 12 618 0.3% | 14 587 14 780 -1.3% | 17 432 16 747 4.09% | 18 327 |
|
EBITDA Million CNY | Released Forecast Spread | 865 820 5.46% | 986 867 13.75% | 1 157 1 049 10.28% | 1 295 1 433 -9.57% | 1 511 1 561 -3.21% | 1 675 |
|
EBIT Million CNY | Released Forecast Spread | 684 664 3.07% | 739 762 -2.95% | 918 914 0.41% | 1 068 1 217 -12.24% | 1 243 1 178 5.52% | 1 306 |
|
Earnings before Tax (EBT) Million CNY | Released Forecast Spread | 692 679 1.89% | 749 772 -2.93% | 957 922 3.79% | 1 097 1 209 -9.31% | 1 235 1 183 4.35% | 1 199 |
|
Net income Million CNY | Released Forecast Spread | 521 540 -3.43% | 604 603 0.13% | 790 748 5.58% | 922 997 -7.56% | 1 010 987 2.34% | 1 042 |
|
EPS CNY | Released Forecast Spread | 0,92 0,94 -2.76% | 1,06 1,06 -0.14% | 1,38 1,27 8.15% | 1,56 1,67 -6.67% | 1,70 1,65 2.59% | 1,75 |
| Announcement Date | 25/02/19 | 27/02/20 | 07/02/21 | 14/03/22 | 17/03/23 | - |
Quarterly results
| Fiscal Period | December | 2021 Q3 | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million CNY | Released Forecast Spread | 3 797 3 634 4.46% | 4 089 4 226 -3.24% | 3 995 4 274 -6.52% | 3 970 3 970 -0% | 4 060 4 367 -7.02% | 5 406 4 723 14.46% | 4 436 4 696 -5.54% | 4 240 4 588 -7.59% | 4 137 4 410 -6.18% | 5 164 | 4 712 | 4 782 | 4 882 | 5 945 |
|
EBITDA Million CNY | Released Forecast Spread | 363 359 1.29% | 127 304 -58.36% | 226 421 -46.43% | 396 421 -5.94% | 434 393 10.43% | 463 | 421 | 392 | 389 | 455 | 442 | 458 | 458 | 541 |
|
EBIT Million CNY | Released Forecast Spread | 269 285 -5.56% | 210 271 -22.35% | 202 370 -45.35% | 253 284 -10.95% | 291 335 -13.01% | 496 392 26.6% | 279 310 -9.99% | 292 345 -15.5% | 216 363 -40.62% | 342 | 328 | 342 | 349 | 408 |
|
Net income Million CNY | Released Forecast Spread | 263 | |||||||||||||
|
EPS CNY | Released Forecast Spread | 0,41 0,41 0.49% | 0,27 0,35 -21.81% | 0,30 0,45 -32.01% | 0,40 0,45 -10.38% | 0,44 0,41 7.67% | 0,56 0,51 9.95% | 0,40 0,40 1.65% | 0,45 0,43 4.32% | 0,30 0,42 -28.67% | 0,39 | 0,40 | 0,43 | 0,41 | 0,50 |
| Announcement Date | 29/10/21 | 14/03/22 | 29/04/22 | 18/08/22 | 27/10/22 | 17/03/23 | 20/04/23 | 19/08/23 | 30/10/23 | - | - | - | - | - |
More events
Past sector events for Yixintang Pharmaceutical Group Co., Ltd.
| 2024-04-21 | SOPHARMA AD: March 2024 Sales and Revenue Release |
| 2024-04-17 | CLICKS GROUP LIMITED: Q2 2024 Earnings Release (Projected) |
| 2024-04-16 12:57 am | DOCMORRIS AG: Q1 2024 Sales and Revenue Release - Trading Update |
| 2024-04-07 | WELCIA HOLDINGS CO., LTD.: Q4 2024 Earnings Release |
| 2024-03-28 07:00 am | WALGREENS BOOTS ALLIANCE, INC.: Q2 2024 Earnings Release |
| 2024-03-21 02:00 am | DOCMORRIS AG: Q4 2023 Earnings Release |
| 2024-03-20 06:00 am | JD HEALTH INTERNATIONAL INC.: Q4 2023 Earnings Release |
| 2024-03-19 | SOPHARMA AD: February 2024 Sales and Revenue Release |
| 2024-03-18 | SIPAI HEALTH TECHNOLOGY CO., LTD.: Q4 2023 Earnings Release |
| 2024-03-18 08:50 am | AL-DAWAA MEDICAL SERVICES COMPANY: Q4 2023 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- 002727 Stock
- Calendar Yixintang Pharmaceutical Group Co., Ltd.
